Search Results - "Lu, YingJuan"

Refine Results
  1. 1

    Folate-mediated delivery of macromolecular anticancer therapeutic agents by Lu, Yingjuan, Low, Philip S.

    Published in Advanced drug delivery reviews (01-12-2012)
    “…The receptor for folic acid constitutes a useful target for tumor-specific drug delivery, primarily because: (1) it is upregulated in many human cancers,…”
    Get full text
    Journal Article
  2. 2

    Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters by Lee, Yong Gu, Chu, Haiyan, Lu, Yingjuan, Leamon, Christopher P., Srinivasarao, Madduri, Putt, Karson S., Low, Philip S.

    Published in Nature communications (18-06-2019)
    “…Although chimeric antigen receptor (CAR) T cell therapies have demonstrated considerable success in treating hematologic malignancies, they have simultaneously…”
    Get full text
    Journal Article
  3. 3

    HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis by Huang, Pinbo, Xu, Qiaodong, Yan, Yongcong, Lu, Yingjuan, Hu, Zhigang, Ou, Bing, Zhang, Heyun, Mao, Kai, Zhang, Jianlong, Wang, Jie, Xiao, Zhiyu

    Published in Oncogene (01-04-2020)
    “…Hepatitis B virus (HBV) infection plays an important role in hepatocarcinogenesis, especially in hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs)…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma by Lu, Yingjuan, Li, Yingru, Wang, Zhangsong, Xie, Shule, Wang, Qing, Lei, Xinyuan, Ruan, Yi, Li, Jinsong

    Published in Biomedicine & pharmacotherapy (01-04-2019)
    “…[Display omitted] •RGMA extremely decreases in OSCC and correlates with T stages and poor prognosis.•RGMA overexpression in OSCC inhibits cell proliferation,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Primary stability analysis of the torque-resistant orthodontic miniscrew anchorage by Ye, Yushan, Zhang, Jianna, Hao, Yunru, He, Jieying, Wang, Yamei, Lu, Yingjuan, Chang, Shaohai

    Published in Advances in mechanical engineering (01-02-2022)
    “…Though miniscrews are widely used as a temporary anchorage device, research focusing on the primary stability of miniscrew loading torque force is limited…”
    Get full text
    Journal Article
  8. 8

    A Novel Prognostic Model for Oral Squamous Cell Carcinoma: The Functions and Prognostic Values of RNA-Binding Proteins by Lu, Yingjuan, Yan, Yongcong, Li, Bowen, Liu, Mo, Liang, Yancan, Ye, Yushan, Cheng, Weiqi, Li, Jinsong, Jiao, Jiuyang, Chang, Shaohai

    Published in Frontiers in oncology (30-07-2021)
    “…Purpose The biological roles and clinical significance of RNA-binding proteins (RBPs) in oral squamous cell carcinoma (OSCC) are not fully understood. We…”
    Get full text
    Journal Article
  9. 9

    Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors by YINGJUAN LU, LOW, Philip S

    Published in Cancer Immunology, Immunotherapy (01-05-2002)
    “…A variety of human cancers overexpress a cell surface receptor with high affinity for the vitamin, folic acid ( K(d) approximately 10(-10)M). Covalent…”
    Get full text
    Journal Article
  10. 10

    Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys by Chu, Haiyan, Shillingford, Jonathan M, Reddy, Joseph A, Westrick, Elaine, Nelson, Melissa, Wang, Emilia Z, Parker, Nikki, Felten, Albert E, Vaughn, Jeremy F, Xu, Le-Cun, Lu, Yingjuan J, Vlahov, Iontcho R, Leamon, Christopher P

    Published in Molecular pharmaceutics (03-09-2019)
    “…Folate-based small molecule drug conjugates (SMDCs) are currently under development and have shown promising preclinical and clinical results against various…”
    Get full text
    Journal Article
  11. 11

    Folate-Hapten-Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer by Bandara, N Achini, Bates, Cody D, Lu, Yingjuan, Hoylman, Emily K, Low, Philip S

    Published in Molecular cancer therapeutics (01-03-2017)
    “…The overexpression of folate receptors (FR) on many human cancers has led to the development of folate-linked drugs for the imaging and therapy of…”
    Get full text
    Journal Article
  12. 12

    Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects by Lu, Yingjuan, Low, Philip S.

    Published in Journal of controlled release (28-08-2003)
    “…The cell surface receptor for the vitamin folic acid (termed the folate receptor), is often elevated in cancers of the ovary, kidney, lung, mammary gland,…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14
  15. 15

    Finite Element Analysis of Orthodontic Relapse in Different Maxillary Arch Form by Li, Yuanyuan, Shao, Yiting, Yu, Yansong, Ye, Yushan, Lu, Yingjuan, Chang, Shaohai

    Published in BIO Integration (Online) (2021)
    “…Abstract Background: Orthodontic relapse is fairly common; however, the mechanisms between relapse and the dental arch form remain unclear. The purpose of our…”
    Get full text
    Journal Article
  16. 16

    Folate receptor‐targeted immunotherapy: Induction of humoral and cellular immunity against hapten‐decorated cancer cells by Lu, Yingjuan, Sega, Emanuela, Low, Philip S.

    Published in International journal of cancer (20-09-2005)
    “…We previously exploited the frequent overexpression of folate receptors on cancer cells to decorate malignant cell surfaces selectively with folate‐hapten…”
    Get full text
    Journal Article
  17. 17

    Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis by Elo, Petri, Li, Xiang-Guo, Liljenbäck, Heidi, Gardberg, Maria, Moisio, Olli, Miner, Maxwell, Virta, Jenni, Saraste, Antti, Srinivasarao, Madduri, Pugh, Michael, Low, Philip S, Knuuti, Juhani, Jalkanen, Sirpa, Airas, Laura, Lu, Yingjuan June, Roivainen, Anne

    Published in Journal of neuroinflammation (20-01-2021)
    “…Activated macrophages in the experimental model of multiple sclerosis (MS) express folate receptor-β (FR-β), representing a promising target for the treatment…”
    Get full text
    Journal Article
  18. 18

    Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases by Henne, Walter A., Kularatne, Sumith A., Ayala-López, Wilfredo, Doorneweerd, Derek D., Stinnette, Torian W., Lu, Yingjuan, Low, Philip S.

    Published in Bioorganic & medicinal chemistry letters (01-01-2012)
    “…A folate receptor targeted didemnin B conjugate was synthesized using a hydrophilic peptide spacer linked to folate via a releasable disulfide carbonate…”
    Get full text
    Journal Article
  19. 19

    Low-Dose Radiation Potentiates the Therapeutic Efficacy of Folate Receptor–Targeted Hapten Therapy by Sega, Emanuela I., Ph.D, Lu, Yingjuan, Ph.D, Ringor, Michael, Ph.D, Leamon, Christopher P., Ph.D, Low, Philip S., Ph.D

    “…Purpose Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to…”
    Get full text
    Journal Article
  20. 20

    Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate–targeted immunotherapy in hapten-immunized mice by Lu, Yingjuan, Xu, Le-Cun, Parker, Nikki, Westrick, Elaine, Reddy, Joseph A, Vetzel, Marilynn, Low, Philip S, Leamon, Christopher P

    Published in Molecular cancer therapeutics (01-12-2006)
    “…Folic acid (pteroylglutamic acid) represents a useful ligand for targeted cancer therapies because it binds to a common epithelial tumor antigen known as the…”
    Get full text
    Journal Article